Search results

Detailed data on ANSTO electricity use and CO2 emissions for FY2022 - FY2023

ANSTO offers capabilities and expertise for the radiation testing and accreditation of space-based systems.

Southern Sydney Innovation Network (SSIN) is calling all innovators, creators, ideas people and entrepreneurs in Southern Sydney to become part of this community driven, not-for-profit group supporting startups and entrepreneurs.

The Macromolecular Crystallography beamlines at the Australian Synchrotron (MX1 and MX2) are general purpose crystallography instruments for determining chemical and biological structures.

A collaboration of scientists from RMIT, ANSTO and the CSIRO has published pioneering research that brings new insights into intrinsically disordered proteins and protein regions (IDPs)/ (IDRs) and how they behave under various physiological processes.

In space, without the protection of the magnetosphere, the type and dose of radiation is considerably different to what is naturally experienced on earth.

A world-first processing technology developed in collaboration by ANSTO’s Minerals unit.

The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.

Recognition of research that developed a life-saving pharmaceutical milkshake using synchrotron techniques.

Every two years the IYNC bring delegates together to discuss various themes within the nuclear industry - this year's being Diversity in Nuclear.

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.